Eton Pharmaceuticals Inc
NASDAQ:ETON

Watchlist Manager
Eton Pharmaceuticals Inc Logo
Eton Pharmaceuticals Inc
NASDAQ:ETON
Watchlist
Price: 14.17 USD -0.91% Market Closed
Market Cap: 380m USD

Wall Street
Price Targets

ETON Price Targets Summary
Eton Pharmaceuticals Inc

Wall Street analysts forecast ETON stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ETON is 29.58 USD with a low forecast of 26.26 USD and a high forecast of 36.75 USD.

Lowest
Price Target
26.26 USD
85% Upside
Average
Price Target
29.58 USD
109% Upside
Highest
Price Target
36.75 USD
159% Upside
Eton Pharmaceuticals Inc Competitors:
Price Targets
DMP
Dermapharm Holding SE
35% Upside
2M7C
China Medical System Holdings Ltd
6% Downside
CRMD
CorMedix Inc
17% Upside
INVA
Innoviva Inc
157% Upside
SAN
Sanofi SA
37% Upside
ATAI
ATAI Life Sciences NV
264% Upside
ROG
Roche Holding AG
15% Upside

Revenue
Forecast

Revenue Estimate
Eton Pharmaceuticals Inc

The compound annual growth rate of Eton Pharmaceuticals Inc's revenue for the next 3 years is 61%.

N/A
Past Growth
61%
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Eton Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Net Income
Forecast

Net Income Estimate
Eton Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-16%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ETON's stock price target?
Price Target
29.58 USD

According to Wall Street analysts, the average 1-year price target for ETON is 29.58 USD with a low forecast of 26.26 USD and a high forecast of 36.75 USD.

What is Eton Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
61%

The compound annual growth rate of Eton Pharmaceuticals Inc's revenue for the next 3 years is 61%.

Back to Top